Arena Pharmaceuticals, Inc. (ARNA) Posts Q3 Loss of $0.38, Misses by 4c
More News related to ARNA
- StockPreacher.com Issues Trading Outlook for Arena Pharmaceuticals Inc.
- Arena Pharmaceuticals, Inc. (ARNA) Posts Q3 Loss of $0.38, Misses by 4c
- Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments
- Trading Radar for 11/09: Dish Network (DISH), Rockwell (ROK), Priceline.com (PCLN), MBIA (MBI), Ticketmaster (TKTM) Report
- Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, November 10, 2009
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) reports Q3 loss of $0.38, versus the analyst estimate of ($0.34). Revenue for the quarter was $2.62 million, which compares to the estimate of $2.43 million.
Related Categories
EarningsStocks Mentioned
-0.03Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
